Paying users zone. Data is covered by 
.
Get to Bristol-Myers Squibb Co. for $17.99, or
get to entire website for at least 3 months from $49.99.
Profitability Analysis
Difficulty: Beginner
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Ratios (Summary)
Bristol-Myers Squibb Co., profitability ratios
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Bristol-Myers Squibb Co.’s gross profit margin deteriorated from 2015 to 2016 and from 2016 to 2017. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Bristol-Myers Squibb Co.’s operating profit margin improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Bristol-Myers Squibb Co.’s net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017. |
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Bristol-Myers Squibb Co.’s ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Bristol-Myers Squibb Co.’s ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017. |
Gross Profit Margin
Bristol-Myers Squibb Co., gross profit margin calculation, comparison to benchmarks
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
2017 Calculations
1 Gross profit margin = 100 × Gross margin ÷ Revenues
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Bristol-Myers Squibb Co.’s gross profit margin deteriorated from 2015 to 2016 and from 2016 to 2017. |
Operating Profit Margin
Bristol-Myers Squibb Co., operating profit margin calculation, comparison to benchmarks
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
2017 Calculations
1 Operating profit margin = 100 × Operating income ÷ Revenues
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Bristol-Myers Squibb Co.’s operating profit margin improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level. |
Net Profit Margin
Bristol-Myers Squibb Co., net profit margin calculation, comparison to benchmarks
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
2017 Calculations
1 Net profit margin = 100 × Net earnings attributable to BMS ÷ Revenues
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Bristol-Myers Squibb Co.’s net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017. |
Return on Equity (ROE)
Bristol-Myers Squibb Co., ROE calculation, comparison to benchmarks
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
2017 Calculations
1 ROE = 100 × Net earnings attributable to BMS ÷ Total Bristol-Myers Squibb Company shareholders’ equity
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Bristol-Myers Squibb Co.’s ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017. |
Return on Assets (ROA)
Bristol-Myers Squibb Co., ROA calculation, comparison to benchmarks
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
2017 Calculations
1 ROA = 100 × Net earnings attributable to BMS ÷ Total assets
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Bristol-Myers Squibb Co.’s ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017. |